Evidence map›Paper›PMID 17389233›Full record

ArticleThe Journal of cell biology2007

The actin-based motor protein myosin II regulates MHC class II trafficking and BCR-driven antigen presentation.

Fulvia Vascotto, Danielle Lankar, Gabrielle Faure-André, Pablo Vargas, Jheimmy Diaz, Delphine Le Roux, Maria-Isabel Yuseff, Jean-Baptiste Sibarita, Marianne Boes, Graça Raposo and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 113 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Fulvia VascottoInstitut National de la Santé et de la Recherche Medicale Unité 653, Unité Mixte de Recherche 144 Institut Curie, 75005 Paris, France.
Danielle Lankar
Gabrielle Faure-André
Pablo Vargas
Jheimmy Diaz
Delphine Le Roux
Maria-Isabel Yuseff
Jean-Baptiste Sibarita
Marianne Boes
Graça Raposo
Evelyne Mougneau
Nicolas Glaichenhaus
Christian Bonnerot
Bénédicte Manoury
Ana-Maria Lennon-Duménil
Inserm · FRInstitut National de Recherche en Santé Publique · MLInstitut Curie · FRInstitut de Pharmacologie Moléculaire et Cellulaire · FRHarvard University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antigen (Ag) capture and presentation onto major histocompatibility complex (MHC) class II molecules by B lymphocytes is mediated by their surface Ag receptor (B cell receptor [BCR]). Therefore, the transport of vesicles that carry MHC class II and BCR-Ag complexes must be coordinated for them to converge for processing. In this study, we identify the actin-associated motor protein myosin II as being essential for this process. Myosin II is activated upon BCR engagement and associates with MHC class II-invariant chain complexes. Myosin II inhibition or depletion compromises the convergence and concentration of MHC class II and BCR-Ag complexes into lysosomes devoted to Ag processing. Accordingly, the formation of MHC class II-peptides and subsequent CD4 T cell activation are impaired in cells lacking myosin II activity. Therefore, myosin II emerges as a key motor protein in BCR-driven Ag processing and presentation.

Indexed as

ActinsAnimalsAntigen PresentationB-LymphocytesCD4-Positive T-LymphocytesCells, CulturedHistocompatibility Antigens Class IILymphocyte ActivationLysosomesMacromolecular SubstancesMiceMice, TransgenicMyosin Type IIProtein TransportReceptors, Antigen, B-CellTransport VesiclesActinsHistocompatibility Antigens Class IIMacromolecular SubstancesMyosin Type IIReceptors, Antigen, B-Cell

Identifiers

PMID17389233
PMCPMC2064085
OpenAlexW2116100639

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.